(Q49108463)

18 February 2018

title

Inflammation in Alzheimer's disease: insights from immunotherapy. (English)

1 reference

18 February 2018

0 references

0 references

1 reference

Jonathan M Schott

1

1 reference

18 February 2018

Tamas Revesz

series ordinal

2

1 reference

18 February 2018

language of work or name

English

0 references

publication date

1 September 2013

1 reference

18 February 2018

published in

Brain

1 reference

18 February 2018

volume

136

1 reference

18 February 2018

page(s)

2654-2656

1 reference

18 February 2018

issue

Pt 9

1 reference

18 February 2018

Inflammation and Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Genetic insights in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer's-like disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

TREM2 Variants in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Current status of vaccination therapies in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Microglia in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWT231

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWT231

1 reference

18 February 2018

PubMed ID

23983027

1 reference

18 February 2018